<bill session="116" type="h" number="6660" updated="2020-09-09T19:45:11Z">
  <state datetime="2020-05-01">REFERRED</state>
  <status>
    <introduced datetime="2020-05-01"/>
  </status>
  <introduced datetime="2020-05-01"/>
  <titles>
    <title type="short" as="introduced">Limit Ongoing Shortages and Stabilize Supply Act of 2020</title>
    <title type="short" as="introduced">Limit Ongoing Shortages and Stabilize Supply Act of 2020</title>
    <title type="short" as="introduced">LOSS Act of 202</title>
    <title type="short" as="introduced">LOSS Act of 2020</title>
    <title type="display">LOSS Act of 2020</title>
    <title type="official" as="introduced">To amend the Federal Food, Drug, and Cosmetic Act to require the holders of approved applications for drugs to conduct a risk assessment to identify and evaluate risks to their supply chain and develop, maintain, and implement risk mitigation plans to address such risks, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="B001303"/>
  <cosponsors>
    <cosponsor bioguide_id="C001103" joined="2020-05-01"/>
    <cosponsor bioguide_id="H001081" joined="2020-06-11"/>
    <cosponsor bioguide_id="J000032" joined="2020-05-12"/>
    <cosponsor bioguide_id="K000386" joined="2020-05-12"/>
  </cosponsors>
  <actions>
    <action datetime="2020-05-01">
      <text>Introduced in House</text>
    </action>
    <action datetime="2020-05-01" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="HSIF" name="House Energy and Commerce" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Administrative law and regulatory procedures"/>
    <term name="Department of Health and Human Services"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Government information and archives"/>
    <term name="Government studies and investigations"/>
    <term name="Health technology, devices, supplies"/>
    <term name="Manufacturing"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <committee-reports/>
</bill>
